The current valuation score of Grifols SA is 9.11, ranking 47 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 9.54, which is 1415.14% below the recent high of 144.48 and 7558.42% above the recent low of -711.21.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.